Speaker illustration

Professor Guangyuan Song

Beijing AnZhen Hospital affiliated to Capital Medical University, Beijing (China)

Mainly engaged in interventional treatment of degenerative valvular disease, complex coronary intervention, diagnosis and treatment of diabetes mellitus with coronary heart disease, evaluation of microcirculation function after interventional treatment of coronary heart disease. Been invited as speaker or moderator both in domestic and international academic conferences. Being a leader expert in China Transcatheter Aortic Valve Replacement(TAVR) and China Occlusion of the Left Atrial Appendage(LAAO). Currently hosting the National Natural Youth Fund, the Doctoral Fund of the Ministry of Education, the Concord Youth Fund and many other topics. Reported the research results in the CSI, CHC and CIT conference. Secretary of "The Chinese Society of Cardiology Cardiovascular Committee Structural Group" Secretary-general of "Asia-Pacific Structural Heart Disease Youth Club" Secretary-general of "China Structural Week committee"

Transcatheter mitral and tricuspid valve intervention in China.

Event: ESC Congress 2021 - The Digital Experience

Topic: Valvular Heart Disease

Session: Global perspectives on structural heart disease


This platform is supported by

logo Novo Nordisk